Semler Scientific Inc (SMLR) Director Sells $67,400.00 in Stock
Semler Scientific Inc (NASDAQ:SMLR) Director Herbert J. Semler sold 20,000 shares of the company’s stock in a transaction that occurred on Wednesday, September 13th. The shares were sold at an average price of $3.37, for a total value of $67,400.00. Following the completion of the transaction, the director now directly owns 130,000 shares of the company’s stock, valued at $438,100. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.
Semler Scientific Inc (SMLR) traded up 1.37% during midday trading on Friday, hitting $3.70. The stock had a trading volume of 11,925 shares. The company’s market cap is $20.21 million. Semler Scientific Inc has a 12-month low of $1.28 and a 12-month high of $3.97. The company has a 50-day moving average price of $3.38 and a 200-day moving average price of $2.99.
Semler Scientific (NASDAQ:SMLR) last posted its quarterly earnings data on Wednesday, August 2nd. The medical equipment provider reported ($0.16) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.11) by ($0.05). The business had revenue of $2.58 million during the quarter, compared to the consensus estimate of $2.23 million. Equities analysts anticipate that Semler Scientific Inc will post ($0.36) EPS for the current year.
TRADEMARK VIOLATION WARNING: This piece of content was originally posted by American Banking News and is owned by of American Banking News. If you are reading this piece of content on another website, it was copied illegally and republished in violation of international copyright and trademark legislation. The original version of this piece of content can be accessed at https://www.americanbankingnews.com/2017/09/15/semler-scientific-inc-smlr-director-sells-67400-00-in-stock.html.
Semler Scientific Company Profile
Semler Scientific, Inc develops, manufactures and markets products and services that assist healthcare insurers and physician groups in evaluating and treating chronic diseases. The Company markets QuantaFlo and WellChec to its customers. QuantaFlo is an approximately four-minute in-office blood flow test.
Receive News & Ratings for Semler Scientific Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Semler Scientific Inc and related companies with MarketBeat.com's FREE daily email newsletter.